Randomized Trialhigh evidence
Re: Testosterone Treatment in Prostate Cancer Survivors with Hypogonadism: A Randomized Clinical Trial.
European urology·July 15, 2026·PMID 42457457
Why it mattersProstate cancer survivors with hypogonadism face a challenging balance between symptom relief and oncologic safety. This trial provides high-level evidence on whether testosterone therapy can be safely used in this population, directly informing clinical decision-making for oncologists and longevity specialists managing these patients.
The papers that matter, first.
MedLit ranks the medical literature into a specialty feed with concise summaries, evidence-aware triage, and visual takeaways.
§
MedLit · Evidence, Distilled